GlassScriptPhysician profile
Luke M Mccrone
NPI 1831457779
$2,601.76
in general payments reported to CMS, 2019-2025
15 companies · $46.47 in 2025
The $46.47 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $83.17 · 2021: $19.50 · 2022: $710 · 2023: $906 · 2024: $521 · 2025: $46.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432 · Education: $41.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.07 |
| Education | $41.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $918.19 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $358.62 | 2022-2024 | Xifaxan |
| Olympus America INC. | $198.06 | 2019-2023 | Evis Exera Lll Colonovideoscope |
| Janssen Biotech, INC. | $193.18 | 2019-2024 | Stelara, Simponi, Remicade |
| Intercept Pharmaceuticals, INC. | $192.83 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $191.31 | 2019-2025 | Entyvio, Eohilia |
| Gilead Sciences, INC. | $176.02 | 2023 | Epclusa |
| Genzyme Corporation | $137.03 | 2022-2024 | |
| Ambu INC. | $51.73 | 2020 | |
| Organon LLC | $43.47 | 2024-2025 | Hadlima, Renflexis |
| Daiichi Sankyo INC. | $33.21 | 2024 | Injectafer |
| Amgen INC. | $32.16 | 2022 | |
| Alnylam Pharmaceuticals INC. | $31.98 | 2023 | Givlaari |
| Ipsen Biopharmaceuticals, INC | $23.66 | 2024 | Bylvay |
| Nestle Healthcare Nutrition INC. | $20.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Mccrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.